International Clinical Laboratories (ICL)

International Clinical Laboratories (ICL) is an advanced diagnostic pathology and medical testing network operating across Africa. Founded in 2004 and operating in strategic partnership with Cerba Lancet Africa, ICL delivers international-standard clinical laboratory diagnostics, anatomical pathology, and preventive health screenings through a network of accredited facilities and patient service centers.

Strategic Framework

| Component | Definition & Objectives | | --- | --- | | Vision | To be the leading diagnostic laboratory network in Africa, delivering accessible, world-class diagnostic services. | | Mission | To enhance the quality of life across the continent by deploying modern technical infrastructure and clinical expertise to address evolving healthcare needs. | | Core Values | Customer-centricity, clinical integrity, quality excellence, professionalism, and patient safety. |

Core Diagnostic Services & Capabilities

• Clinical Pathology & Routine Testing: Comprehensive hematology, clinical chemistry, serology, immunology, and microbiology diagnostics.
• Specialized & Molecular Diagnostics: Molecular testing, histocytology, tissue biopsy analysis, immunohistochemistry (IHC), and advanced referral testing.
• Preventive Health & Wellness: Age- and gender-tailored wellness packages (e.g., MyLab Check) focusing on early disease detection and metabolic health.
• Digital Laboratory Integration: Real-time laboratory information systems linking partner clinics and hospitals for rapid test turnaround and electronic record integration.

Pan-African Network (Cerba Lancet Africa)

ICL operates as part of the Cerba Lancet Africa regional diagnostic alliance, with partner networks and presence across:

• Botswana
• Eswatini
• Ethiopia
• Gabon
• Ghana
• Ivory Coast
• Kenya
• Mozambique
• Nigeria
• Rwanda
• Tanzania
• Uganda
• Zambia
• Zimbabwe